Sonic Incytes is a medical technology company that specializes in developing and providing innovative medical devices for non-invasive liver disease assessment.

Sonic Incytes Medical Corp.

Sonic Incytes

Sonic Incytes is dedicated to developing accessible solutions that provide health insights to enhance patient care. In response to the growing prevalence of chronic liver disease, Sonic Incytes is determined to establish liver health as a new vital sign. Their novel point-of-care ultrasound-based imaging solution, Velacur™, is redefining the standard of care in quantifying liver tissue stiffness and attenuation as an aid in the clinical management of patients with chronic liver disease.

Creative Destruction Lab (CDL)

entrepreneurship@UBC

World Changing Ventures

Small World Group

Sunhope Capital

Think Top Investments

TMFOX

UBC Seed Fund

Genome British Columbia

E-Fund

Wavemaker 360

Nicola Wealth Management

MEDTEQ+

Mint Venture Partners

Gaingels

Nimbus Synergies Inc.

INP Capital

Sonic Incytes is gearing up for NASH-TAG Conference 2024! 

We'll be in Park City, UT from January 4-6, 2024. Join us in highlighting the most relevant advances and challenges in the diagnosis and therapy of NASH and liver fibrosis. Come watch a live demo, or have your own liver scanned and discover how Velacur™ can elevate your practice.

#NASHTAG2024 #SonicIncytes #LiverHealth #Velacur #FattyLiverDisease #NASH #NAFLD #LiverDisease

Happy Thanksgiving from our team to yours! We wanted to thank everyone who visited our booth at American Association for the Study of Liver Diseases (AASLD), The Liver Meeting in Boston, MA.

Our team showcased how Velacur™ equips physicians with an advanced liver imaging tool to combat the growing epidemic of fatty liver disease.

#TLM2023 #AASLD2023 #TheLiverMeeting #LiverHealth #FattyLiverDisease #NASH #NAFLD #LiverDisease"

In just a few days, our Sonic Incytes team will be heading to American Association for the Study of Liver Diseases (AASLD), The Liver Meeting in Boston, MA, from November 10-14, 2023!

Come visit us at Booth D2900 to experience Velacur™, the first in-office liver assessment tool using 3D-S-WAVE technology offering real-time quantification of liver stiffness and attenuation. Join us to watch a live demo, or have your own liver scanned and discover how Velacur, can elevate your practice.

Don't miss the chance to connect with us at this premier event in the field of liver health!

#TLM2023 #AASLD2023 #TheLiverMeeting #LiverHealth #SonicIncytes #Velacur #FattyLiverDisease #NASH #NAFLD #LiverDisease

COM:SONICINCYTES

Sonic Incytes

locale

market

industry

website

crunchbase

linkedin

peer of

Metrics